Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients-Reference-Cited by-同舟云学术

Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients

Published:2017-01-06 Issue:5 Volume:65 Page:1566-1580
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Xiang Daimin¹²,Cheng Zhuo¹,Liu Hui³,Wang Xue¹,Han Tao¹⁴,Sun Wen¹,Li Xiaofeng¹,Yang Wen¹,Chen Cheng¹,Xia Mingyang¹,Liu Na⁵,Yin Shengyong⁶,Jin Guangzhi⁷,Lee Terence⁸,Dong Liwei¹,Hu Heping⁵,Wang Hongyang¹⁹,Ding Jin¹⁹

Affiliation:

1. International Cooperation Laboratory on Signal Transduction; Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University; Shanghai China

2. Nelson Institute of Environmental Medicine; New York University School of Medicine; New York NY

3. The Third Department of Hepatic Surgery; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University; Shanghai China

4. Department of Oncology; General Hospital of Shenyang Military Region; Shenyang China

5. Department of Hepatobiliary Medicine; Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University; Shanghai China

6. Department of General Surgery; First Affiliated Hospital, College of Medicine, Zhejiang University; Hangzhou China

7. Department of Pathology; Eastern Hepatobiliary Surgery Hospital/Institute, Second Military Medical University; Shanghai China

8. Department of Pathology; Li Ka Shing Faculty of Medicine, the University of Hong Kong; Pokfulam Hong Kong

9. National Center for Liver Cancer; Shanghai China

Funder

National Natural Science Foundation of China

Ministry of Science and Technology Key Program

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28919/fullpdf

Reference52 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

3. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

4. Cancer stem cells: impact, heterogeneity, and uncertainty;Magee;Cancer Cell,2012

5. Characteristics of liver cancer stem cells and clinical correlations;Cheng;Cancer Lett,2016

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression;Frontiers of Medicine;2024-04-11

2. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?;Frontiers in Immunology;2024-03-05

3. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities;Genes & Diseases;2024-03

4. Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer;Cell Death & Disease;2024-02-03

5. Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease;Current Drug Targets;2024-02